Stockscreener 앱 받기
0.2997
0.10%
-0.0003
시간 외 거래:
.30
0.0003
+0.10%
전일 마감가:
$0.30
열려 있는:
$0.305
하루 거래량:
137.01K
Relative Volume:
0.78
시가총액:
$2.85M
수익:
-
순이익/손실:
$-25.83M
주가수익비율:
-0.0444
EPS:
-6.7442
순현금흐름:
$-21.77M
1주 성능:
-9.35%
1개월 성능:
-59.04%
6개월 성능:
-80.54%
1년 성능:
-96.90%
1일 변동 폭
$0.2916
$0.3076
1주일 범위
$0.2916
$0.3302
52주 변동 폭
$0.2916
$19.20
Calidi Biotherapeutics Inc Stock (CLDI) Company Profile
명칭
Calidi Biotherapeutics Inc
전화
(858) 794-9600
주소
4475 Executive Drive, Suite 200, San Diego
Compare CLDI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLDI
Calidi Biotherapeutics Inc
|
0.2997 | 2.85M | 0 | -25.83M | -21.77M | -6.7442 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-22 | 개시 | H.C. Wainwright | Buy |
| 2023-10-09 | 개시 | Robert W. Baird | Outperform |
Calidi Biotherapeutics Inc 주식(CLDI)의 최신 뉴스
Calidi Biotherapeutics (CLDI) stock plunges 35% after hours — here's why - MSN
Calidi Biotherapeutics prices $5.2M underwritten public offering - MSN
Can Calidi Biotherapeutics Inc keep up with sector leaders2026 Key Highlights & Intraday High Probability Alerts - baoquankhu1.vn
Portfolio Recap: How much upside does Calidi Biotherapeutics Inc have2026 Market Mood & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company’s Approach to Manufacturing - Sahm
Calidi Biotherapeutics Prices Public Offering at $0.50 per Unit - Intellectia AI
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing - Bitget
Calidi Biotherapeutics Announces Proposed Public Offering of Common Stock and Warrants to Fund Growth Initiatives 12 - Minichart
Calidi Biotherapeutics Completes Dilutive Public Equity Offering - TipRanks
Calidi Biotherapeutics announces underwritten public offering - Investing.com Nigeria
Calidi Biotherapeutics Raises $6.03 Million in Unit Offering; Adds Warrant Agent and Amends Legacy Warrants - TradingView
Calidi Biotherapeutics (NYSE: CLDI) closes $6M unit and warrant deal - Stock Titan
Portfolio Update: Is Calidi Biotherapeutics Inc a stock for growth or value investors2026 Trading Volume Trends & Accurate Buy Signal Alerts - baoquankhu1.vn
CLDI PE Ratio & Valuation, Is CLDI Overvalued - Intellectia AI
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option - Bitget
Calidi Biotherapeutics Announces Closing of $6.0 Million - GlobeNewswire
Calidi Biotherapeutics closes $6M public offering - Investing.com
Calidi Biotherapeutics closes $6M public offering By Investing.com - Investing.com India
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option - The Manila Times
Biotech Calidi raises $6M now, lines up $12M more with new warrants - Stock Titan
Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire Inc.
Investor Ognian Gavrilov reports 9.8% Calidi Biotherapeutics (CLDI) stake in Schedule 13D - Stock Titan
Calidi Biotherapeutics Prices $5.2 Mln Public Offering Of Shares And Warrants - Nasdaq
Published on: 2026-03-07 11:34:48 - baoquankhu1.vn
Growth Value: Is Calidi Biotherapeutics Inc forming a bullish divergenceTreasury Yields & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Stop Loss: Does Calidi Biotherapeutics Inc have pricing powerJuly 2025 Summary & Daily Chart Pattern Signals - baoquankhu1.vn
Crude Oil Jumps Over 12%; US Retail Sales Fall In January - Benzinga
Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering - Bitget
Calidi prices 10.5M units at 50c in underwritten public offering - TipRanks
Calidi Biotherapeutics announces pricing of $5.2 million underwritten public offering - marketscreener.com
Calidi Biotherapeutics Announces Pricing Of $5.2 Million Underwritten Public Offering - TradingView
Calidi Biotherapeutics announces underwritten public offering By Investing.com - Investing.com Canada
Calidi Biotherapeutics (CLDI) Stock Plunges 35% After HoursHere's Why - Finviz
Calidi Biotherapeutics Announces Public Offering, Shares Plunge 31% - Intellectia AI
Calidi Sinks On Proposed Public Offering; Shares Hit New 52-Week Low - Nasdaq
Calidi Biotherapeutics Announces Proposed Public Offering - The Manila Times
Biotech Calidi plans stock-and-warrant sale for working capital - Stock Titan
Calidi details characterization of CLD-401 for solid tumor treatment - BioWorld MedTech
CLDI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Quarterly Earnings: Is Calidi Biotherapeutics Inc a stock for growth or value investors - baoquankhu1.vn
CLDICalidi Biotherapeutics Inc Latest Stock News & Market Updates - Stock Titan
Is Calidi Biotherapeutics Inc. a momentum stockQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
Can Calidi Biotherapeutics Inc. keep up with sector leadersJuly 2025 Fed Impact & Weekly Top Performers Watchlists - mfd.ru
Will Calidi Biotherapeutics Inc. stock benefit from AI adoptionEarnings Beat & Pattern Based Trade Signal System - mfd.ru
New virus-based tactic aims to revive T-cell engagers for solid tumors - Stock Titan
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference - The Manila Times
Will Calidi Biotherapeutics Inc. stock maintain strong growthEarnings Overview Summary & Safe Capital Investment Plans - mfd.ru
Energy Moves: Why analysts remain bullish on Calidi Biotherapeutics Inc. stockJuly 2025 Gainers & Community Verified Trade Signals - mfd.ru
Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference - Bitget
Engineered virus from Calidi delivers BiTEs into solid tumors - Stock Titan
Calidi Biotherapeutics Inc (CLDI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):